Dingdang Health Technology Group Ltd.
DNGHF
$0.14
$0.0217.12%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.95% | -4.12% | -5.29% | -0.95% | 2.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.95% | -4.12% | -5.29% | -0.95% | 2.32% |
| Cost of Revenue | -5.10% | -6.48% | -7.85% | -2.59% | 1.74% |
| Gross Profit | 1.55% | 0.95% | 0.36% | 2.61% | 3.55% |
| SG&A Expenses | -2.81% | -3.06% | -3.32% | -0.02% | 2.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.19% | -5.26% | -6.32% | -1.90% | 1.49% |
| Operating Income | 29.90% | 26.66% | 24.12% | 18.35% | 13.15% |
| Income Before Tax | -73.77% | -69.14% | -64.65% | 78.56% | 92.19% |
| Income Tax Expenses | -4.68% | -2.23% | 1.09% | 12.76% | 22.83% |
| Earnings from Continuing Operations | -69.12% | -65.59% | -62.01% | 77.89% | 91.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -126.52% | -81.75% | -33.81% | -19.66% | -7.54% |
| Net Income | -74.66% | -69.32% | -64.20% | 78.14% | 91.94% |
| EBIT | 29.90% | 26.66% | 24.12% | 18.35% | 13.15% |
| EBITDA | 35.01% | 30.92% | 27.76% | 20.37% | 13.31% |
| EPS Basic | -75.73% | -70.27% | -65.27% | 82.18% | 93.56% |
| Normalized Basic EPS | 30.58% | 29.85% | 28.57% | 89.29% | 93.95% |
| EPS Diluted | -75.73% | -70.27% | -65.27% | 82.18% | 93.56% |
| Normalized Diluted EPS | 30.58% | 29.85% | 28.57% | 89.29% | 93.95% |
| Average Basic Shares Outstanding | -1.39% | -1.30% | -1.21% | 4.60% | 11.11% |
| Average Diluted Shares Outstanding | -1.39% | -1.30% | -1.21% | 4.60% | 11.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |